Carvedilol improves functional class in patients with severe left ventricular dysfunction referred for heart transplantation
- 1 October 1999
- journal article
- Published by Wiley in Clinical Transplantation
- Vol. 13 (5) , 426-431
- https://doi.org/10.1034/j.1399-0012.1999.130509.x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Effects of Beta-Adrenergic Blockade on Survival of Patients With Chronic Heart FailureThe American Journal of Cardiology, 1997
- Apoptosis in the Failing Human HeartNew England Journal of Medicine, 1997
- Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart diseaseThe Lancet, 1997
- Carvedilol Inhibits Clinical Progression in Patients With Mild Symptoms of Heart FailureCirculation, 1996
- Double-Blind, Placebo-Controlled Study of the Effects of Carvedilol in Patients With Moderate to Severe Heart FailureCirculation, 1996
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996
- A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees.Circulation, 1994
- Beneficial effects of metoprolol in idiopathic dilated cardiomyopathyThe Lancet, 1993
- The pharmacology of carvedilolEuropean Journal of Clinical Pharmacology, 1990
- Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy.Heart, 1975